Modelling the consumption of anxiolytics and its addictive behaviour

[1]  J. Clarke,et al.  Medicine , 1907, Bristol medico-chirurgical journal.

[2]  E H Wagner,et al.  A chronic disease score from automated pharmacy data. , 1992, Journal of clinical epidemiology.

[3]  P Tyrer,et al.  Benzodiazepine Dependence , 1993, Drug safety.

[4]  Gregory E. Simon,et al.  A Chronic Disease Score with Empirically Derived Weights , 1995, Medical care.

[5]  J. D. L. Fuente,et al.  Prescribed daily doses and ‘risk factors’ associated with the use of benzodiazepines in primary care , 1999, Pharmacoepidemiology and drug safety.

[6]  D. Malone,et al.  Development of a chronic disease indicator score using a Veterans Affairs Medical Center medication database. IMPROVE Investigators. , 1999, Journal of clinical epidemiology.

[7]  F. Alla,et al.  Factors associated with the consumption of psychotropic drugs in a cohort of men and women aged 50 and over , 2003, Journal of clinical pharmacy and therapeutics.

[8]  Farmacovigilancia . Agencia.  UTILIZACIÓN DE ANSIOLÍTICOS E HIPNÓTICOS EN ESPAÑA (1995-2002) , 2004 .

[9]  Leida M Lamers,et al.  The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. , 2004, Health policy.

[10]  C. Vedia Urgell,et al.  Estudio de utilización de psicofármacos en atención primaria , 2005 .

[11]  Sami Pirkola,et al.  Treatment of anxiety disorders in the Finnish general population. , 2006, Journal of affective disorders.

[12]  M. G. Ramírez,et al.  Variables asociadas a la depresión: un modelo de regresión logística , 2006 .

[13]  Francisco Cutanda Henríquez.  Datos anómalos y regresión logística robusta en ciencias de la salud , 2008 .

[14]  Benoit Barthelme,et al.  Niveau d’anxiété et de dépendance des primoconsommants d’anxiolytiques : une étude de psychométrie , 2008 .

[15]  M. García-Goñi,et al.  Hybrid risk adjustment for pharmaceutical benefits , 2009, The European Journal of Health Economics.

[16]  S. Antich Arqué,et al.  Estudio de la utilización de ansiolíticos, hipnóticos y antidepresivos desde farmacias comunitarias , 2008 .

[17]  B. Barthelmé,et al.  [Anxiety level and addiction to first-time prescriptions of anxiolytics: a psychometric study]. , 2008, Presse medicale.

[18]  E. Isometsä,et al.  Use of health services for major depressive and anxiety disorders in Finland , 2008, Depression and anxiety.

[19]  Pierre Verger,et al.  Dispensing of anxiolytics and hypnotics in southeastern France: demographic factors and determinants of geographic variations , 2008, Fundamental & clinical pharmacology.

[20]  S. Demarest,et al.  Gender differences in the use of anxiolytics and antidepressants: a population based study , 2009, Pharmacoepidemiology and drug safety.

[21]  Sami Pirkola,et al.  Treatment of major depressive disorder in the Finnish general population , 2009, Depression and anxiety.

[22]  Tjeerd P van Staa,et al.  Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. , 2010, Bone.